His mother, Leah Levin (died 2024), was an honorary doctorate from the University of Essex[3] and was appointed OBE for services to international human rights in 2001.

[7] Following the Sharpeville massacre, his family left South Africa and moved to live in Salisbury, Rhodesia (now Harare, Zimbabwe).

[8] Following graduating from high school, Levin went to Wadham College, University of Oxford, where he gained a First Class BA Honors degree in zoology, and a Master of Arts (MA) and doctorate (DPhil) in cell biology and chromatin structure from the Oxford University's Sir William Dunn School of Pathology.

[10] Levin is the chairman and CEO of Ovid Therapeutics Inc., a company dedicated to meaningfully improve the lives if people and families affected by neurological diseases.

[11][12] Ovid is developing a next generation of targeted small molecule therapies that seek to reduce seizures and deliver improved safety and tolerability.

Ovid’s current product development programs are focused on restoring neuronal homeostasis, targeting conditions such as epilepsy and cerebral cavernous malformation.

[13][14] Previously, he was a member of the executive committee of Bristol-Myers Squibb (NYSE:BMY), where he had global responsibilities for strategy, alliances and transactions.

In his speech at the Kellogg-Recanati International Executive MBA Program in Tel Aviv, Levin addressed the importance of leadership, innovation, and global collaboration.

[25][26] Levin was also invited to speak as part of the Keck Graduate Institute’s (KGI) 25 Years of Innovation Speaker Series.